Edition:
United Kingdom

Iovance Biotherapeutics Inc (IOVA.OQ)

IOVA.OQ on NASDAQ Stock Exchange Global Market

9.42USD
18 Jan 2019
Change (% chg)

$0.06 (+0.64%)
Prev Close
$9.36
Open
$9.37
Day's High
$9.54
Day's Low
$9.29
Volume
294,365
Avg. Vol
507,172
52-wk High
$19.80
52-wk Low
$7.27

Chart for

About

Iovance Biotherapeutics, Inc., formerly Lion Biotechnologies, Inc., is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of cancer immunotherapy products designed to harness the power of a patient's own immune system to eradicate cancer cells. The Company's lead program... (more)

Overall

Beta: 4.58
Market Cap(Mil.): $552.43
Shares Outstanding(Mil.): 70.37
Dividend: --
Yield (%): --

Financials

  IOVA.OQ Industry Sector
P/E (TTM): -- 69.71 33.71
EPS (TTM): -2.11 -- --
ROI: -49.36 8.99 14.48
ROE: -80.46 10.13 15.99

Earnings vs. Estimates